|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Internal Medicine (Dr. Haponik), Section on Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Wake Forest University School of Medicine (Dr. Chin), Winston-Salem, NC; and North Shore Hospital (Dr. Fein), New York, NY.
Correspondence to: Edward F. Haponik, MD, FCCP, Professor of Medicine, Director of Clinical Operations, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Room 301, Baltimore, MD 21205
| Abstract |
|---|
|
|
|---|
Design: Survey during a computer-assisted interactive continuing medical education presentation.
Setting: The 1998 American College of Chest Physicians (ACCP) Annual Scientific Assembly.
Participants: Chest clinicians attending the respiratory emergency symposium.
Results: Most clinicians (86%) had cared for patients with life-threatening hemoptysis, and 28% had cared for patients with fatal events during the previous year. Those clinicians favored management in the ICU setting (95%) with early endotracheal intubation (85%), and they tended to use a large-bore, single-lumen endotracheal tube (57%). The majority (64%) favored the early performance of diagnostic bronchoscopy during the first 24 h. Most clinicians (79%) used the flexible instrument, a higher frequency than respondents at a similar symposium on hemoptysis at the 1988 ACCP meeting (48%; p < 0.0001). Most current clinicians (77%) had experience with endobronchial measures to control bleeding, but few (14%) found them to be consistently worthwhile. Chest CT scanning was often helpful in diagnosis (55%). In their management of bleeding, half of these clinicians favored the use of interventional angiography, even in operable patients, which is a substantial change from 1988 when 23% had favored this approach (p < 0.0001).
Conclusions: During the past decade, life-threatening hemoptysis has remained an important problem. Flexible bronchoscopy and interventional angiography have become increasingly established, more widely accepted approaches to patient care.
Key Words: massive hemoptysis respiratory emergencies
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
Eighty-six percent of respondents (111 of 129 respondents) indicated that they had cared for patients with life-threatening hemoptysis during the previous year, and 28% of respondents (44 of 111 respondents) had had a patient die from pulmonary hemorrhage during the previous year. These clinicians overwhelmingly favored the care of such patients in the ICU setting (211 of 223 respondents [95%]). The approaches to airway management favored by respondents are summarized in Table 1 . In general, early endotracheal intubation was favored, but clinicians varied in their strategies. They more often favored the placement of large-bore, single-lumen tubes rather than a double-lumen tube, and they expressed reservations about their own proficiency in consistently placing the latter airways.
|
|
|
| Discussion |
|---|
|
|
|---|
The early timing of the bronchoscopic evaluation favored by most of these clinicians appears to be consistent with the presumed importance of the localization of the bleeding site in order to isolate and protect the nonbleeding lung and/or to facilitate specific therapy. Whether this strategy realizes these goals consistently in patients with life-threatening hemorrhage remains undefined. Although rigid bronchoscopy is the time-honored approach that is recommended for airway evaluation in this setting, generally because the open tube instrument secures the airway and may facilitate a broader array of interventional options, most of these clinicians (79%) reported the use of the flexible instrument. They favored this approach more often than their 1988 counterparts (48%).8 While this strategy undoubtedly reflects familiarity with the current fiberoptic technology (as well as selection bias by this group), it also might suggest that prohibitively high morbidity has not been encountered when the flexible instrument is used via an already secured airway. While there has been particular emphasis placed on a variety of endobronchial therapies purported to help control massive bleeding, the majority of these respondents who had used such treatments did not find them to be consistently worthwhile. The survey did not address the emerging applications of cryotherapy or laser photocoagulation in the treatment of major airway hemorrhage.
Interestingly, approximately half of the 1998 respondents found chest CT scanning to be helpful in appraising patients with life-threatening bleeding, a frequency similar to that reported in 1988 (60%). Although the frequencies of CT use were similar, we believe that the influence of this modality on the care of these patients may increase in the future because of important technologic developments. A previous review of the use of CT scanning in the general evaluation of patients with hemoptysis showed that such imaging more often identified the bleeding site than the conventional posteroanterior and lateral chest radiograph but that the information obtained by the CT scan seldom influenced patient management.9 More recently, CT scanning performed with a newer generation of scanners has had a high diagnostic yield and impact on decision making in such patients.10 Well-suited for delineating bronchiectasis, neoplastic disease, tuberculosis, necrotizing infection, vascular abnormalities, and other major causes of life-threatening hemoptysis, CT scan findings also may clarify radiologic details that would otherwise be obscured by atelectasis and/or aspirated blood. While the practical use of CT scanning in critically ill patients has been limited by scanning duration and other factors, newly available helical ("spiral") scanners allow rapid scanning, making timely examination feasible. Additional options including CT angiography, multiplanar reconstructions, and endobronchial simulations also may enhance the appraisal of life-threatening hemoptysis. In preliminary experiences, "virtual bronchoscopy" derived from helical CT scan data sets has helped to characterize more completely airway disease.11 Few patients with life-threatening bleeding have been included in such reports, however, and the role of CT scanning and its impact on outcomes in this acute setting require further study.
The views of these clinicians about approaches to early treatment were particularly informative. In 1988, only 21% of survey respondents advocated interventional angiography for most patients with massive hemoptysis, and only 2% favored this modality in all patients.8 Nearly one third of respondents were undecided about the role of this therapy, and 45% reserved it for inoperable patients only. By contrast, half of the present respondents favored interventional angiography as an early approach to therapy. We believe this changing viewpoint reflects the further validation of interventional angiography for this indication during the past decade, together with the more widespread availability of this modality.11 12 13 14 Newer microcatheters that allow superselective catheterization, better selection of embolic materials, and enhanced training in interventional radiology, and the perception of a relatively low frequency of complications also may have helped to popularize the procedure.15 The rates of initial control of bleeding have ranged from 77 to 95%, enhancing the acceptance of early angiographic intervention despite the fact that it is rarely curative, complications are not rare, and recurrence rates are relatively high. It is not clear whether the watchful waiting approach favored by one quarter of the current respondents reflects the spontaneous resolution of even massive bleeding in some patients and/or its association with extensive chronic parenchymal disease that often precludes meaningful intervention.
Because of time constraints, the current survey was necessarily abbreviated and did not include important demographic data about respondents. Such factors as the relative proportions of thoracic surgeons, anesthesiologists, pulmonologists, and full-time intensivists, their levels of experience, and the settings of their practices might be expected to influence the approaches to patients with life-threatening hemoptysis. In addition, comparisons with the survey administered 10 years previously were limited to those areas in which both the context and the content of the questions and the optional answers were similar. It is likely that a more comprehensive survey that includes more details relating to patient evaluation and management as well as characterization of respondents and their practices would be even more informative about current approaches. We anticipate that such an expanded instrument would refine observations about differences in practice style and would be strongly influenced by regional variations in the epidemiology of hemoptysis and by the availability of institutional resources for diagnosis and therapy.
Other important limitations include selection bias due to sampling highly motivated physicians attending the ACCP international conference, and inaccuracies related to incomplete survey options or respondents imprecise recollections about experiences. Nevertheless, these observations present interesting insights into current approaches to a classic dilemma in respiratory medicine. Life-threatening hemoptysis remains an important problem to be managed by chest clinicians and generally requires ICU management. Although many aspects of acute care continue to be highly individualized and have not changed substantially over time, during the past decade early flexible bronchoscopy and interventional angiography appear to have become increasingly established, more widely accepted approaches. Whether these modalities, other nuances of care, or future technologic innovations contribute to improved patient outcomes in this high-risk setting requires future investigation.
| Acknowledgements |
|---|
| Footnotes |
|---|
Received for publication October 13, 1999. Accepted for publication May 23, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Khalil, A. Parrot, C. Nedelcu, M. Fartoukh, C. Marsault, and M.-F. Carette Severe Hemoptysis of Pulmonary Arterial Origin: Signs and Role of Multidetector Row CT Angiography Chest, January 1, 2008; 133(1): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reisz Topical Hemostatic Tamponade: Another Tool in the Treatment of Massive Hemoptysis Chest, June 1, 2005; 127(6): 1888 - 1889. [Full Text] [PDF] |
||||
![]() |
A. Valipour, A. Kreuzer, H. Koller, W. Koessler, and O. C. Burghuber Bronchoscopy-Guided Topical Hemostatic Tamponade Therapy for the Management of Life-Threatening Hemoptysis Chest, June 1, 2005; 127(6): 2113 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J L Lordan, A Gascoigne, and P A Corris The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis Thorax, September 1, 2003; 58(9): 814 - 819. [Full Text] [PDF] |
||||
![]() |
S. Endo, S.-i. Otani, N. Saito, T. Hasegawa, Y. Kanai, Y. Sato, and Y. Sohara Management of massive hemoptysis in a thoracic surgical unit Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yoon, Y. H. Kim, J. K. Kim, Y. C. Kim, J. G. Park, and H. K. Kang Massive Hemoptysis: Prediction of Nonbronchial Systemic Arterial Supply with Chest CT Radiology, April 1, 2003; 227(1): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yoon, J. K. Kim, Y. H. Kim, T. W. Chung, and H. K. Kang Bronchial and Nonbronchial Systemic Artery Embolization for Life-threatening Hemoptysis: A Comprehensive Review RadioGraphics, November 1, 2002; 22(6): 1395 - 1409. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |